Fig. 1From: Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG studyFlow chart of recruitment and inclusion of SELENON-RM or LAMA2-MD patientsBack to article page